Crescentic glomerulonephritis occurs in a wide range of kidney diseases, including IgA nephropathy, anti-glomerular basement membrane GN, anti-neutrophil cytoplasmic antibody-mediated GN, lupus nephritis, and type I membranoproliferative GN1. of BRD4 Inhibitor-10 pro-inflammatory STAT3 target genes was significantly reduced in nephritic mice with, compared to those without, podocyte STAT3 deletion. However, the extent of glomerular immune complex deposition was not different. Podocytes with STAT3 deletion were resistant to interleukin-6-induced STAT3 phosphorylation and pro-inflammatory STAT3 target gene expression. Thus, podocyte STAT3 activation is critical for the development of crescentic glomerulonephritis. Keywords:Glomerulonephritis, podocyte, signaling, glomerulus, proliferation == Introduction == Accumulation of hyperplastic glomerular epithelial cells in Bowmans space is observed in both crescentic glomerulonephritis (GN) and collapsing glomerulopathy. Crescentic glomerulonephritis occurs in a wide range of kidney diseases, including IgA nephropathy, anti-glomerular basement membrane GN, anti-neutrophil cytoplasmic antibody-mediated GN, lupus nephritis, and type I membranoproliferative GN1. Collapsing glomerulopathy is observed in patients with HIV-1 seropositivity2, other viral infections3,4, pamidronate toxicity5, and de novo or recurrent idiopathic collapsing glomerulopathy in the renal allograft6. Although histologic features of these two entities are differentcrescentic GN7is characterized by inflammatory changes in glomerular capillaries with focal or diffuse necrosis of glomerular capillaries, while collapsing glomerulopathy8is associated with segmental to global collapse of the glomerular capillary tuftextracapillary proliferation of glomerular epithelial cells is observed in both conditions. Presence of glomerular crescents on kidney biopsy is associated worse prognosis in patients with glomerulonephritis9. Recent studies of human and animal model of crescentic GN have documented the accumulation of podocytes1012as well as parietal epithelial cells (PECs)13,14in crescentic lesions. In addition to collapsing glomerulopathy and crescentic GN, prominent epithelial cell proliferation has also been observed in murine BRD4 Inhibitor-10 models where the primary cell-specific stimulus/insult was directed to either BRD4 Inhibitor-10 the podocyte11,15or PEC16. These findings provide additional evidence that injury to either glomerular epithelial cell type could precipitate glomerular epithelial cells (podocytes, PECs or both) to proliferate and form cellular crescents. Signaling pathways orchestrating this proliferative response in crescent formation, however, have been not characterized. Signal transducers and activators of transcription (STAT)-mediated signaling is involved in the regulation of cell proliferation and inflammation17. STAT3 signaling is activated in kidneys of mice18and human19with GN. Furthermore, activation of podocytes STAT3 has also been shown to drive the proliferation and dedifferentiation of podocytes in collapsing glomerulopathy due to HIV-1 infection20,21. In the present study we evaluate the role of podocyte STAT3 on crescent formation by comparing the development of immune complex-mediated crescentic GN in mice with and without podocyte-specific STAT3 deletion. == Results == == Mice with podocyte-specific deletion of STAT3 == We generated a line of mice (Cre+;STAT3f/f) withCre-mediated deletion of aStat3floxed allele (Stat3f)22driven by a podocyte-specific, 2.5-kb humanNPHS2promoter23. To demonstrate that STAT3 deletion occurred in podocytes of Cre+;STAT3f/fmice we performed polymerase chain reaction to detect the presence of the wild-type, floxed, or exon-18-to-20-deletedStat3alleles (Stat3+,Stat3f, andStat, respectively) (Supp. Figure 1a and b).Statwas detected in the glomerular fraction (Glom), non-glomerular fraction (NGF) and the kidney cortex (Cortex) and completely absent in non-renal samples (i.e. Tail or Liver) (Supp. Figure 1c). Lower levels of Statin NGF and Cortex compared to Glom reflect the minor amount of glomerular contamination in those samples.Statwas absent in glomeruli of Cre+;STAT3+/+mice, but present in both Cre+;STAT3+/fand Cre+;STAT3f/fmice (Supp. Figure 1d). To compare the expression of podocyte STAT3 between Cre+;STAT3f/fand Cre+;STAT3+/+mice we performed co-immunolabeling of STAT3 and Wilms Tumor (WT)-1, which is expressed by podocytes and parietal epithelial cells (PEC), but not by endothelial cells and mesangial cells. Since PECs can be distinguished from podocytes based on their localization within the glomerulusPECs localize to the periphery and podocytes localize to center of the glomeruluswe examined STAT3 labeling of WT-1-positive nuclei close to the middle of glomerular tuft. We verified that Goat polyclonal to IgG (H+L)(FITC) STAT3 staining was absent in WT-1-positive nuclei of Cre+ almost;STAT3f/fmice (Amount 1a). To verify that podocyte STAT3 is low in Cre+ further;STAT3f/fmice we performed traditional western blotting for total and Y7095-phosphorylated STAT3 (p-STAT3) on principal glomerular epithelial cells (PGEC) isolated from decapsulated glomeruli. Phosphorylation and Appearance of STAT3 were low in PGECs of Cre+;STAT3f/fmice in comparison to Cre+;STAT3+/+mice (Amount 1b).Stat3mRNA transcript degrees of PGECs from Cre+;STAT3f/fwas 0.1430.039 fold of Cre+;STAT3+/+(P<0.05, n=4 mice per group)..